Switch to Joana Gil's research page...

2007

1. Araujo IM, Gil J, Carreira BP, Mohapel P, Petersen A, Pinheiro PS, Malva JO, Bahr BA, Brundin P, and Carvalho CM. Early calpain activation mediates caspase-independent excitotoxic degeneration in the hippocampus of epileptic rats J Neurochem. (Submitted) (2007).
    Request Paper

2006

2. Bjorkqvist M, Petersen A, Bacos K, Isaacs J, Norlen P, Gil J, Popovic N, Sundler F, Bates GP, Tabrizi SJ, Brundin P, and Mulder H . Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease Hum Mol Genet 15:10 p.1713-1721 (2006).
    [View Abstract - PubMed 16613897]  Request Paper

3. Winkler C, Gil J, Araujo IM, Riess O, Skripuletz T, von Horsten S, and Petersen, A. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat Brain Res Bull 69:3 p.306-310 (2006).
    [View Abstract - PubMed 16564426]  Request Paper

2005

4. Araujo IM, Xapelli S, Gil J, Mohapel P, Petersen A, Pinheiro PS, Malva JO, Bahr BA, Brundin P, and Carvalho CM . Proteolysis of NR2B by calpain in the hippocampus of epileptic rats Neuroreport 16:4 p.393-396 (2005).
    [View Abstract - PubMed 15729144]  Request Paper

5. Bjorkqvist M, Fex M, Renstron E, Wierup N, Petersen A, Gil J, Bacos K, Popovic N, Li JY, Sundler F, Brundin P, and Mulder H. The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass Hum Mol Genet 14:5 p.565-574 (2005).
    [View Abstract - PubMed 15649949]  Request Paper

6. Gil J, Mohapel P, Araujo IM, Popovic N, Li JY, Brundin P, and Petersen . Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice Neurobiol Dis 20:3 p.744-751 (2005).
    [View Abstract - PubMed 15951191]  Request Paper

7. Petersen, A, Gil J, Maat-Schieman MLC, Bjorkqvist M, Tanila H, Araujo IM, Smith, R, Popovic N, Wierup N, Norlen P, Li JY, Roos RAC, Sundler F, Mulder H, and Brundin P. Orexin loss in Huntington's disease Hum Mol Genet 14:1 p.39-47 (2005).
    [View Abstract - PubMed 15525658]  Request Paper

2004

8. Gil J, Leist M, Popovic N, Brundin P, and Petersen A. Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice BMC Neuroscience 5:17-27 (2004).
    [View Abstract - PubMed 15134587]  Request Paper

2003

9. Gil J, Almeida S, Oliveira CR, and Rego AC . Cytosolic and mitochondrial ROS in staurosporine-induced retinal cell apoptosis Free Radic Biol Med 35:11 p.1500-1514 (2003).
    [View Abstract - PubMed 14642398]  Request Paper

10. Rego AC, Monteiro NM, Silva AP, Gil J, Malva JO, and Oliveira CR . Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures J Neurochem 86:4 p.792-804 (2003).
     [View Abstract - PubMed 12887678]  Request Paper

2007

1. Gil J, and Rego AC. Mechanisms of neurodegeneration in Huntington's disease Eur J Neurosci. (Submitted). (2007).
    Request Paper

2004

1. Araujo IM, Gil J, Petersen A, Mohapel P, Malva JO, Pinheiro PS, Bahr BA, Brundin P, and Carvalho CM. Calpain-mediated proteolysis in the epileptic hippocampus and neurodegenerative events Program No. 567.12. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. Online. (2004).
    Request Paper

2. Araujo IM, Gil J, Petersen A, Mohapel P, Malva JO, Pinheiro PS, Bahr BA, Brundin P, and Carvalho CM . Proteolytic events and cell death in rat hippocampus following status epilepticus: involvement of calpains FENS Abstr. 2: A124.05 (2004).
    Request Paper

3. Gil J, Mohapel P, Araujo IM, Popovic N, Li JY, Brundin P, and Petersen A. Transgenic Huntington's disease mice display reduced hippocampal neurogenesis FENS Abstr. 2: A020.10 (2004).
    Request Paper

4. Gil J, Mohapel P, Araujo IM, Popovic N, Li JY, Brundin P, and Petersen A. Progressive reduction in hippocampal neurogenesis in the R6/2 transgenic mouse model of Huntington's disease Program No. 564.5. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. Online. (2004).
    Request Paper

5. Petersen A, Gil J, Maat-Schieman MLC, Bjorkqvist M, Mohapel P, Tanila H, Araujo IM, Smith R, Popovic N, Wierup N, Norlen P, Li JY, Roos RAC, Sundler F, Mulder H, and Brundin P . The sleeping dancers: hypothalamic neuropathology in the R6 mouse model of Huntington's disease FENS Abstr. 2: A020.25 (2004).
    Request Paper

6. Petersen A, Gil J, Maat-Schieman, MLC, Bjorkqvist M, Mohapel P, Tanila H, Araujo IM, Smith R, Popovic N, Wierup N, Norlen P, Li JY, Roos RAC, Sundler F, Mulder H, and Brundin P. Orexin loss: more evidence for hypothalamic dysfunction in Huntington's disease Program No. 564.1. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. Online. (2004).
    Request Paper

2002

7. Gil J, Rego AC, and Oliveira CR . Mitochondrial and cytosolic sources of ROS are involved in staurosporine-induced apoptosis in retinal neurons FENS Abstr. 1: A149.13 (2002).
    Request Paper

8. Gil J, Rego AC, and Oliveira CR . Increased ROS generation and intracellular calcium are involved in staurosporine-induced apoptosis in retinal neurons Free Radic Biol Med 33:1 p. S12, abstract 18 (2002).
    Request Paper

9. Rego AC, Gil J, and Oliveira CR . Intracellular reactive oxygen species control apoptosis induced by staurosporine in retinal neurons Program No. 493.14. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience Abstracts. CD-ROM (2002).
    Request Paper

2001

10. Gil J, Rego AC, and Oliveira CR . Reactive oxygen species are implicated in the activation of caspase-3 during staurosporine-induced apoptosis in retinal cells Eur J Biochem 268:1 PS4-056 (2001).
     Request Paper